Cellebrite (CLBT) reported Q1 adjusted earnings Thursday of $0.12 per diluted share, compared with $0.10 a year earlier.
Analysts surveyed by FactSet expected $0.10.
Revenue for the quarter ended March 31 was $128.3 million, compared with $107.5 million a year earlier.
Analysts surveyed by FactSet expected $127 million.
The company expects Q2 revenue of $130 million to $133 million, and 2026 revenue of $565 million to $571 million.
Analysts polled by FactSet expect Q2 and 2026 revenue of $135 million and $568.5 million, respectively.
Shares of Cellebrite were down more than 4% pre-bell.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments